Study guide

12.1 UAE Regulatory Framework & Licensing Authorities

DHA Pharmacist Licensing Assessment PHO5481

Track your progress as you read

Finished sections get a check mark.

1 Exam Overview & Licensing Pathway

1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan

2 Cardiovascular Pharmacology

2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents

3 Endocrine & Metabolic Pharmacology

3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents

4 Anti-Infective Pharmacology

4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars

5 CNS, Psychiatric & Pain Pharmacology

5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine

6 Respiratory, GI & Hematology Pharmacology

6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents

7 Pharmaceutical Care: Cardiometabolic Disease

7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management

8 Pharmaceutical Care: Respiratory, Rheumatology & Infection

8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship

9 Counseling, Monitoring & Special Populations

9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making

10 Pharmaceutical Calculations I

10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation

11 Pharmaceutical Calculations II

11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents

12 UAE Pharmacy Law & Regulation

12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity

13 Controlled Drugs, Ethics & Pharmacovigilance

13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal

14 Pharmacokinetics I: ADME

14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination

15 Pharmacokinetics II: Kinetics, Dosing & TDM

15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring

16 OTC Medicines & Self-Care

16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin

17 Medication Safety

17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition

18 Sterile & Nonsterile Compounding

18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding

19 Pharmaceutics, Biopharmaceutics & Toxicology

19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes

20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics

20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics

12.1 UAE Regulatory Framework & Licensing Authorities

Key Takeaways Explain This Topic AI

Three health authorities license pharmacists in the UAE: DHA (Dubai), DOH (Abu Dhabi), and MOHAP (the Northern Emirates), each issuing licenses valid only within its own jurisdiction

Federal Decree-Law No. 38 of 2024 on Medical Products, the Pharmacy Profession and Pharmaceutical Establishments is the current cornerstone statute, in force from 2 January 2025; it repealed Federal Law No. 8 of 2019 (which had repealed the original Federal Law No. 4 of 1983)

The Emirates Drug Establishment (EDE), established in 2023, is the current federal regulator for medical products — registration, pricing, market surveillance and pharmacovigilance — under Decree-Law No. 38 of 2024; MOHAP remains the ministry and licensing authority for the Northern Emirates

Every pharmacy must have a licensed pharmacist-in-charge; premises and professionals are licensed separately and both must be current

Dubai licensing runs through the Sheryan portal; a pharmacist moving between emirates generally needs a new licence (often with Primary Source Verification via DataFlow and sometimes an additional assessment)

Last updated: August 2026

Who Regulates Pharmacy in the UAE?

Unlike countries with a single national regulator, the United Arab Emirates (UAE) licenses healthcare professionals and facilities through three separate health authorities , each with exclusive jurisdiction over its own territory:

Authority Jurisdiction Notes

Dubai Health Authority (DHA) Emirate of Dubai Licenses facilities and professionals in Dubai; professional licensing runs through the Sheryan online portal. Note that 'Dubai Health' now refers to the government academic health system delivering care, while DHA remains the regulator.

Department of Health – Abu Dhabi (DOH) Emirate of Abu Dhabi Formerly known as the Health Authority – Abu Dhabi (HAAD); the same exam content may still reference HAAD.

Ministry of Health and Prevention (MOHAP) The Northern Emirates Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, plus federal public-health functions.

A DHA licence authorises practice only in Dubai . A pharmacist moving to Abu Dhabi must obtain a DOH licence, and one moving to Sharjah needs a MOHAP licence. This is one of the most-tested practical points on the DHA exam.

Toward unification: the PQR

To reduce duplication, the three authorities collaborated on a unified Professional Qualification Requirements (PQR) document that sets common minimum standards (recognised pharmacy degree, internship, experience, good standing) for licensure across the UAE. In practice this means the criteria are largely harmonised, but the licence itself remains emirate-specific. Verification of credentials is typically done by Primary Source Verification (PSV) through the DataFlow Group, and an eligibility/assessment exam may be required depending on the authority and the applicant's background.

  • The Federal Legal Framework
  • Federal Decree-Law No. 38 of 2024

The current cornerstone statute is Federal Decree-Law No. 38 of 2024 on Medical Products, the Pharmacy Profession and Pharmaceutical Establishments , in force from 2 January 2025 . It repealed Federal Law No. 8 of 2019 (which had itself repealed the original Federal Law No. 4 of 1983) and is now the single governing instrument for:

Medical products — medicines (human and veterinary), medical devices, and related products: registration, manufacture, import, marketing, pricing and pharmacovigilance.

The pharmacy profession — who may practise as a pharmacist or pharmacy technician, licensing conditions, and professional obligations.

Pharmaceutical establishments — community pharmacies, hospital pharmacies, pharmaceutical warehouses/stores, factories, marketing offices and consulting offices: how they are licensed and inspected.

The law also embeds core principles the exam likes to test: no medical product may be circulated in the UAE unless registered , pharmacies may dispense prescription-only medicines only against a valid prescription , and controlled medicines are subject to special prescribing, dispensing and record-keeping rules. Candidates should be aware of the predecessor laws (Federal Law No. 8 of 2019 and Federal Law No. 4 of 1983) because some exam material and older references still cite them, but the operative statute is now Decree-Law No. 38 of 2024.

Emirates Drug Establishment (EDE) and MOHAP

The Emirates Drug Establishment (EDE) is the established federal regulator for medical products in the UAE. Created in 2023 as the dedicated federal body for the medical-products sector, EDE is now the primary federal medicines regulator under Decree-Law No. 38 of 2024, responsible for product registration, pricing, market surveillance and pharmacovigilance . The Ministry of Health and Prevention (MOHAP) remains the ministry of health and the licensing authority for the Northern Emirates. Historically, MOHAP performed the federal drug-regulation functions for the whole UAE in addition to licensing the Northern Emirates; those federal product functions have moved to EDE. Candidates should recognise the split: EDE = federal product regulator; MOHAP = ministry + Northern Emirates licensing authority.

Licensing of Establishments and Professionals

The 2024 Decree-Law licenses premises and people separately , and both licences must be valid simultaneously:

Establishment licence — a community pharmacy, hospital pharmacy or pharmaceutical warehouse must be licensed by the relevant health authority before opening. Requirements cover location, premises standards, equipment, storage conditions and staffing.

Professional licence — every pharmacist and pharmacy technician working there must hold an individual licence from the same authority.

Pharmacist-in-charge (responsible pharmacist) — every pharmacy must designate a licensed pharmacist who is legally responsible for its operation, including the safe storage and dispensing of medicines and compliance with controlled-drug rules. A pharmacy cannot lawfully operate to the public without a licensed pharmacist on duty.

Dubai specifics: Sheryan

In Dubai, individual licensing (new applications, renewals, transfers between facilities) is handled through the DHA's Sheryan portal. The typical sequence is: document submission, DataFlow PSV of the degree and experience, eligibility assessment (the DHA pharmacist exam), and licence activation once linked to a licensed facility.

Inspection, compliance and sanctions

Health authority inspectors may enter and inspect pharmaceutical establishments, review records (including controlled-drug registers and cold-chain logs), and take samples. Where breaches are found, Federal Decree-Law No. 38 of 2024 provides for disciplinary sanctions in principle : warnings, fines, suspension or closure of an establishment, and suspension or revocation of a professional licence in serious cases, with criminal liability for the gravest offences such as dealing in falsified medicines. Exact penalty amounts and article references are amended from time to time — candidates should verify specifics against the current text of Decree-Law No. 38 of 2024, its executive regulations, and DHA/MOHAP/DOH circulars rather than memorising figures.

Moving between emirates

Practically, a pharmacist relocating from Dubai to the Northern Emirates would need to apply to MOHAP for a new licence; the unified PQR and existing DataFlow report usually streamline this, but an additional assessment can still be required. A DHA licence never 'converts' automatically — plan for processing time and do not practise in the new emirate until the local licence is active.